Identification of druggable cancer driver genes amplified across TCGA datasets
Chen, Ying, McGee, Jeremy, Chen, Xianming, Doman, Thompson N, Gong, Xueqian, Zhang, Youyan, Hamm, Nicole, Ma, Xiwen, Higgs, Richard E, Bhagwat, Shripad V, Buchanan, Sean, Peng, Sheng-Bin, Staschke, Kirk A, Yadav, Vipin, Yue, Yong, Kouros-Mehr, Hosein
Published in PloS one (29.05.2014)
Published in PloS one (29.05.2014)
Get full text
Journal Article
Reactivation of Mitogen-activated Protein Kinase (MAPK) Pathway by FGF Receptor 3 (FGFR3)/Ras Mediates Resistance to Vemurafenib in Human B-RAF V600E Mutant Melanoma
Yadav, Vipin, Zhang, Xiaoyi, Liu, Jiangang, Estrem, Shawn, Li, Shuyu, Gong, Xue-Qian, Buchanan, Sean, Henry, James R., Starling, James J., Peng, Sheng-Bin
Published in The Journal of biological chemistry (10.08.2012)
Published in The Journal of biological chemistry (10.08.2012)
Get full text
Journal Article
Molecular dissection of CRC primary tumors and their matched liver metastases reveals critical role of immune microenvironment, EMT and angiogenesis in cancer metastasis
Liu, Jiangang, Cho, Yong Beom, Hong, Hye Kyung, Wu, Song, Ebert, Philip J, Bray, Steven M, Wong, Swee Seong, Ting, Jason C, Calley, John N, Whittington, Catherine F, Bhagwat, Shripad V, Reinhard, Christoph, Wild, Robert, Nam, Do-Hyun, Aggarwal, Amit, Lee, Woo Yong, Peng, Sheng-Bin
Published in Scientific reports (01.07.2020)
Published in Scientific reports (01.07.2020)
Get full text
Journal Article
Inhibition of CXCR4 by LY2624587, a Fully Humanized Anti-CXCR4 Antibody Induces Apoptosis of Hematologic Malignancies
Peng, Sheng-Bin, Zhang, Xiaoyi, Paul, Donald, Kays, Lisa M, Ye, Ming, Vaillancourt, Peter, Dowless, Michele, Stancato, Louis F, Stewart, Julie, Uhlik, Mark T, Long, Haiyan, Chu, Shaoyou, Obungu, Victor H
Published in PloS one (08.03.2016)
Published in PloS one (08.03.2016)
Get full text
Journal Article
Identifying metastasis-initiating miRNA-target regulations of colorectal cancer from expressional changes in primary tumors
Lee, Jongmin, Hong, Hye Kyung, Peng, Sheng-Bin, Kim, Tae Won, Lee, Woo Yong, Yun, Seong Hyun, Kim, Hee Cheol, Liu, Jiangang, Ebert, Philip J, Aggarwal, Amit, Jung, Sungwon, Cho, Yong Beom
Published in Scientific reports (10.09.2020)
Published in Scientific reports (10.09.2020)
Get full text
Journal Article
Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers
Ozkan-Dagliyan, Irem, Diehl, J. Nathaniel, George, Samuel D., Schaefer, Antje, Papke, Bjoern, Klotz-Noack, Kathleen, Waters, Andrew M., Goodwin, Craig M., Gautam, Prson, Pierobon, Mariaelena, Peng, Sen, Gilbert, Thomas S.K., Lin, Kevin H., Dagliyan, Onur, Wennerberg, Krister, Petricoin, Emanuel F., Tran, Nhan L., Bhagwat, Shripad V., Tiu, Ramon V., Peng, Sheng-Bin, Herring, Laura E., Graves, Lee M., Sers, Christine, Wood, Kris C., Cox, Adrienne D., Der, Channing J.
Published in Cell reports (Cambridge) (16.06.2020)
Published in Cell reports (Cambridge) (16.06.2020)
Get full text
Journal Article
Mouse PDX Trial Suggests Synergy of Concurrent Inhibition of RAF and EGFR in Colorectal Cancer with BRAF or KRAS Mutations
Yao, Yung-Mae M, Donoho, Gregory P, Iversen, Philip W, Zhang, Youyan, Van Horn, Robert D, Forest, Amelie, Novosiadly, Ruslan D, Webster, Yue Wang, Ebert, Philip, Bray, Steven, Ting, Jason C, Aggarwal, Amit, Henry, James R, Tiu, Ramon V, Plowman, Gregory D, Peng, Sheng-Bin
Published in Clinical cancer research (15.09.2017)
Published in Clinical cancer research (15.09.2017)
Get full text
Journal Article
Identification and expression of novel isoforms of human stromal cell-derived factor 1
Yu, Lan, Cecil, Jeffrey, Peng, Sheng-Bin, Schrementi, James, Kovacevic, Steven, Paul, Donald, Su, Eric Wen, Wang, Jian
Published in Gene (07.06.2006)
Published in Gene (07.06.2006)
Get full text
Journal Article
Distinct mobilization of leukocytes and hematopoietic stem cells by CXCR4 peptide antagonist LY2510924 and monoclonal antibody LY2624587
Peng, Sheng-Bin, Van Horn, Robert D, Yin, Tinggui, Brown, Robin M, Roell, William C, Obungu, Victor H, Ruegg, Charles, Wroblewski, Victor J, Raddad, Eyas, Stille, John R
Published in Oncotarget (07.11.2017)
Published in Oncotarget (07.11.2017)
Get full text
Journal Article
Akt Activation, but not Extracellular Signal–Regulated Kinase Activation, Is Required for SDF-1α/CXCR4–Mediated Migration of Epitheloid Carcinoma Cells
Peng, Sheng-Bin, Peek, Victoria, Zhai, Yan, Paul, Donald C., Lou, Qinyuan, Xia, Xiaoling, Eessalu, Thomas, Kohn, Wayne, Tang, Shaoqing
Published in Molecular cancer research (01.04.2005)
Published in Molecular cancer research (01.04.2005)
Get full text
Journal Article
Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers
Peng, Sheng-Bin, Henry, James R., Kaufman, Michael D., Lu, Wei-Ping, Smith, Bryan D., Vogeti, Subha, Rutkoski, Thomas J., Wise, Scott, Chun, Lawrence, Zhang, Youyan, Van Horn, Robert D., Yin, Tinggui, Zhang, Xiaoyi, Yadav, Vipin, Chen, Shih-Hsun, Gong, Xueqian, Ma, Xiwen, Webster, Yue, Buchanan, Sean, Mochalkin, Igor, Huber, Lysiane, Kays, Lisa, Donoho, Gregory P., Walgren, Jennie, McCann, Denis, Patel, Phenil, Conti, Ilaria, Plowman, Gregory D., Starling, James J., Flynn, Daniel L.
Published in Cancer cell (14.09.2015)
Published in Cancer cell (14.09.2015)
Get full text
Journal Article
Oncogenic BRAF Deletions That Function as Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120
Chen, Shih-Hsun, Zhang, Youyan, Van Horn, Robert D, Yin, Tinggui, Buchanan, Sean, Yadav, Vipin, Mochalkin, Igor, Wong, Swee Seong, Yue, Yong Gang, Huber, Lysiane, Conti, Ilaria, Henry, James R, Starling, James J, Plowman, Gregory D, Peng, Sheng-Bin
Published in Cancer discovery (01.03.2016)
Published in Cancer discovery (01.03.2016)
Get full text
Journal Article
Novel Lipoglycopeptides as Inhibitors of Bacterial Signal Peptidase I
Kulanthaivel, Palaniappan, Kreuzman, Adam J, Strege, Mark A, Belvo, Matthew D, Smitka, Tim A, Clemens, Matthew, Swartling, James R, Minton, Kristina L, Zheng, Feng, Angleton, Eddie L, Mullen, Deborah, Jungheim, Louis N, Klimkowski, Valentine J, Nicas, Thalia I, Thompson, Richard C, Peng, Sheng-Bin
Published in The Journal of biological chemistry (27.08.2004)
Published in The Journal of biological chemistry (27.08.2004)
Get full text
Journal Article
ERK Inhibitor LY3214996 Targets ERK Pathway-Driven Cancers: A Therapeutic Approach Toward Precision Medicine
Bhagwat, Shripad V, McMillen, William T, Cai, Shufen, Zhao, Baohui, Whitesell, Matthew, Shen, Weihua, Kindler, Lisa, Flack, Robert S, Wu, Wenjuan, Anderson, Bryan, Zhai, Yan, Yuan, Xiu-Juan, Pogue, Meghann, Van Horn, Robert D, Rao, Xi, McCann, Denis, Dropsey, Andrew J, Manro, Jason, Walgren, Jennie, Yuen, Eunice, Rodriguez, Michael J, Plowman, Gregory D, Tiu, Ramon V, Joseph, Sajan, Peng, Sheng-Bin
Published in Molecular cancer therapeutics (01.02.2020)
Published in Molecular cancer therapeutics (01.02.2020)
Get full text
Journal Article
A Phase I Study of LY3009120, a Pan-RAF Inhibitor, in Patients with Advanced or Metastatic Cancer
Sullivan, Ryan J, Hollebecque, Antoine, Flaherty, Keith T, Shapiro, Geoffrey I, Rodon Ahnert, Jordi, Millward, Michael J, Zhang, Wei, Gao, Ling, Sykes, Amanda, Willard, Melinda D, Yu, Danni, Schade, Andrew E, Crowe, KrisAnne, Flynn, Daniel L, Kaufman, Michael D, Henry, James R, Peng, Sheng-Bin, Benhadji, Karim A, Conti, Ilaria, Gordon, Michael S, Tiu, Ramon V, Hong, David S
Published in Molecular cancer therapeutics (01.02.2020)
Published in Molecular cancer therapeutics (01.02.2020)
Get full text
Journal Article
Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy
Cho, Byung-Sik, Zeng, Zhihong, Mu, Hong, Wang, Zhiqiang, Konoplev, Sergej, McQueen, Teresa, Protopopova, Marina, Cortes, Jorge, Marszalek, Joseph R., Peng, Sheng-Bin, Ma, Wencai, Davis, R. Eric, Thornton, Donald E., Andreeff, Michael, Konopleva, Marina
Published in Blood (09.07.2015)
Published in Blood (09.07.2015)
Get full text
Journal Article
Identification of LY2510924, a novel cyclic peptide CXCR4 antagonist that exhibits antitumor activities in solid tumor and breast cancer metastatic models
Peng, Sheng-Bin, Zhang, Xiaoyi, Paul, Donald, Kays, Lisa M, Gough, Wendy, Stewart, Julie, Uhlik, Mark T, Chen, Qi, Hui, Yu-Hua, Zamek-Gliszczynski, Maciej J, Wijsman, John A, Credille, Kelly M, Yan, Liang Zeng
Published in Molecular cancer therapeutics (01.02.2015)
Published in Molecular cancer therapeutics (01.02.2015)
Get full text
Journal Article
The CDK4/6 inhibitor LY2835219 overcomes vemurafenib resistance resulting from MAPK reactivation and cyclin D1 upregulation
Yadav, Vipin, Burke, Teresa F, Huber, Lysiane, Van Horn, Robert D, Zhang, Youyan, Buchanan, Sean G, Chan, Edward M, Starling, James J, Beckmann, Richard P, Peng, Sheng-Bin
Published in Molecular cancer therapeutics (01.10.2014)
Published in Molecular cancer therapeutics (01.10.2014)
Get full text
Journal Article
A novel, selective inhibitor of fibroblast growth factor receptors that shows a potent broad spectrum of antitumor activity in several tumor xenograft models
Zhao, Genshi, Li, Wei-Ying, Chen, Daohong, Henry, James R, Li, Hong-Yu, Chen, Zhaogen, Zia-Ebrahimi, Mohammad, Bloem, Laura, Zhai, Yan, Huss, Karen, Peng, Sheng-Bin, McCann, Denis J
Published in Molecular cancer therapeutics (01.11.2011)
Published in Molecular cancer therapeutics (01.11.2011)
Get full text
Journal Article